{"id":"https://openalex.org/W3145541145","doi":null,"title":"Facilitating compliance with antipsychotic medication.","display_name":"Facilitating compliance with antipsychotic medication.","publication_year":1998,"publication_date":"1998-01-01","ids":{"openalex":"https://openalex.org/W3145541145","mag":"3145541145","pmid":"https://pubmed.ncbi.nlm.nih.gov/9541334"},"language":"en","primary_location":{"id":"pmid:9541334","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9541334","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042806742","display_name":"S R Marder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4210108215","display_name":"VA West Los Angeles Medical Center","ror":"https://ror.org/01xfgtq85","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210108215","https://openalex.org/I4210138663","https://openalex.org/I4210156876"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"S R Marder","raw_affiliation_strings":["West Los Angeles Veterans Affairs Medical Center and the University of California at Los Angeles School of Medicine, 90073, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"West Los Angeles Veterans Affairs Medical Center and the University of California at Los Angeles School of Medicine, 90073, USA","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I4210108215"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5042806742"],"corresponding_institution_ids":["https://openalex.org/I161318765","https://openalex.org/I4210108215"],"apc_list":null,"apc_paid":null,"fwci":1.5895,"has_fulltext":false,"cited_by_count":57,"citation_normalized_percentile":{"value":0.83681118,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"59 Suppl 3","issue":null,"first_page":"21","last_page":"5"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.7788000106811523,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.7788000106811523,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.2054000049829483,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13944","display_name":"Psychiatric care and mental health services","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9819999933242798},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.859000027179718},{"id":"https://openalex.org/keywords/newer-antipsychotics","display_name":"newer antipsychotics","score":0.8140000104904175},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-antagonists","display_name":"dopamine D2 receptor antagonists","score":0.753000020980835},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.9909999966621399},{"id":"https://openalex.org/keywords/hospital-readmission","display_name":"hospital readmission","score":0.6449999809265137},{"id":"https://openalex.org/keywords/risk-factor-analysis","display_name":"risk factor assessment","score":0.7319999933242798},{"id":"https://openalex.org/keywords/cognitive-function","display_name":"cognitive function","score":0.6259999871253967},{"id":"https://openalex.org/keywords/therapeutic-relationship","display_name":"therapeutic relationship","score":0.8569999933242798},{"id":"https://openalex.org/keywords/blood-monitoring","display_name":"blood monitoring","score":0.6850000023841858},{"id":"https://openalex.org/keywords/economic-burden","display_name":"economic burden","score":0.734000027179718}],"concepts":[{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.7096673846244812},{"id":"https://openalex.org/C2781460075","wikidata":"https://www.wikidata.org/wiki/Q1399332","display_name":"Compliance (psychology)","level":2,"score":0.6508203744888306},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.493915855884552},{"id":"https://openalex.org/C3018553135","wikidata":"https://www.wikidata.org/wiki/Q67004728","display_name":"Medication adherence","level":2,"score":0.4823179244995117},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46973857283592224},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.412957102060318},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.4000091552734375},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13304394483566284},{"id":"https://openalex.org/C77805123","wikidata":"https://www.wikidata.org/wiki/Q161272","display_name":"Social psychology","level":1,"score":0.07841718196868896}],"mesh":[{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016312","descriptor_name":"Treatment Refusal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017048","descriptor_name":"Health Care Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9541334","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9541334","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Journal Article"},{"id":"mag:3145541145","doi":null,"is_oa":false,"landing_page_url":"https://europepmc.org/article/MED/9541334","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2991148834","https://openalex.org/W2047151451","https://openalex.org/W2057942140","https://openalex.org/W1743894799","https://openalex.org/W7132007704","https://openalex.org/W2937234665","https://openalex.org/W1877317565","https://openalex.org/W2012449264","https://openalex.org/W2003475832","https://openalex.org/W2123064624"],"abstract_inverted_index":{"Noncompliance":[0],"with":[1,49],"medication":[2],"is":[3,11],"common":[4],"among":[5,160],"patients":[6,31,41,118,161],"who":[7,32,42,162],"have":[8,26,43,46,57,163],"schizophrenia":[9,44,75,164],"and":[10,22,54,79,84,98,112,124],"a":[12,106,145],"leading":[13],"cause":[14],"of":[15,74,92,108,144,169],"rehospitalization":[16],"in":[17,70],"this":[18,158,170],"population.":[19],"Both":[20],"standard":[21],"subjective":[23],"risk-factor":[24],"assessments":[25],"been":[27,47],"used":[28],"to":[29,35,119,127,152,172],"identify":[30],"are":[33,68],"likely":[34],"refuse":[36],"or":[37],"discontinue":[38],"treatment.":[39],"Noncompliant":[40],"commonly":[45],"treated":[48],"potent":[50],"D2":[51],"dopamine-receptor":[52],"antagonists":[53],"therefore":[55],"may":[56,88,101,165],"experienced":[58],"extrapyramidal":[59],"side":[60,81],"effects.":[61,82],"The":[62,94,130],"newer":[63,86],"antipsychotics":[64,87],"(i.e.,":[65],"serotonin-dopamine":[66],"antagonists)":[67],"efficacious":[69],"reducing":[71],"the":[72,142,150,167],"symptoms":[73],"without":[76],"associated":[77],"dysphoria":[78],"motor":[80],"Clozapine":[83],"other":[85],"improve":[89],"certain":[90],"aspects":[91],"cognition.":[93],"improved":[95,122],"psychiatric":[96],"state":[97,123],"cognitive":[99,115],"function":[100],"facilitate":[102,141],"\"involved":[103],"compliance\"":[104],"as":[105],"result":[107],"increased":[109],"insight,":[110],"awareness,":[111],"judgment.":[113],"These":[114],"faculties":[116],"allow":[117],"appreciate":[120],"their":[121],"take":[125],"steps":[126],"maintain":[128],"it.":[129],"periodic":[131],"visits":[132],"for":[133,137],"blood":[134],"monitoring":[135],"mandated":[136],"clozapine":[138],"therapy":[139],"also":[140],"formation":[143],"therapeutic":[146],"alliance":[147],"that":[148],"allows":[149],"clinician":[151],"monitor":[153],"compliance.":[154],"Facilitating":[155],"involved":[156],"compliance":[157],"way":[159],"reduce":[166],"cost":[168],"disorder":[171],"society.":[173]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-04-13T00:00:00"}